{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:18:50Z","timestamp":1789769930211,"version":"4.0.1"},"publisher-location":"Chichester, UK","reference-count":108,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003510.pub2","type":"reference-entry","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"source":"Crossref","is-referenced-by-count":69,"title":["Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection"],"prefix":"10.1002","author":[{"given":"Jimmy","family":"Volmink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandi","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lize","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Brocklehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"key":"10.1002\/14651858.CD003510.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.qai.0000185572.90849.4d","article-title":"Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission","volume":"40","author":"Bhoopat","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB3|cit2","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1097\/00002030-200104130-00013","article-title":"18-Month mortality and perinatal exposure to zidovudine in West Africa","volume":"15","author":"Dabis","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB4|cit3","article-title":"Infant mortality and perinatal exposure to zidovudine in Africa","volume":"Abstract MoPpB1","author":"Dabis","year":"2000","journal-title":"XIII International AIDS Conference, Durban"},{"key":"10.1002\/14651858.CD003510.pub2-BIB5|cit4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(98)11046-2","article-title":"6-month efficacy, tolerance and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial","volume":"353","author":"Dabis","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB6|cit5","first-page":"Suppl A:S67-74","article-title":"Methodology of intervention trials to reduce mother to child transmission of HIV with special reference to developing countries. International Working Group on Mother to Child Transmission of HIV","volume":"9","author":"Dabis","year":"1995","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB2|cit6","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0140-6736(99)04388-3","article-title":"15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/00002030-199810000-00026","article-title":"Prevention of mother-to-child transmission of HIV in Africa: uptake of pregnant women in a clinical trial in Abidjan, Cote d'Ivoire","volume":"12","author":"Msellati","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.aids.0000180100.42770.a7","article-title":"A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers","volume":"19","author":"Gray","year":"2005","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB9|cit9","doi-asserted-by":"crossref","DOI":"10.1097\/01.qai.0000219772.74432.20","article-title":"Antiviral activity of nucleoside analogues during short-course monotherapy or dual therapy: Its role in preventing HIV infection in infants","volume":"42","author":"Gray","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB10|cit10","author":"See Gray"},{"key":"10.1002\/14651858.CD003510.pub2-BIB11|cit11","author":"See Gray"},{"key":"10.1002\/14651858.CD003510.pub2-BIB12|cit12","author":"See Gray"},{"key":"10.1002\/14651858.CD003510.pub2-BIB13|cit13","first-page":"593","article-title":"Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012","volume":"39","author":"Eshleman","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.qai.0000174656.71276.d6","article-title":"Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012","volume":"40","author":"Eshleman","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/430764","article-title":"Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP","volume":"192","author":"Eshleman","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/430742","article-title":"Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012","volume":"192","author":"Flys","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(03)14341-3","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial","volume":"362","author":"Jackson","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB19|cit19","unstructured":"James JS IOM: nevirapine study is reliable AIDS Treatment News 411"},{"key":"10.1002\/14651858.CD003510.pub2-BIB20|cit20","series-title":"XIII International AIDS Conference, Durban","article-title":"The one year safety and efficacy data of HIVNET 012 trial","author":"Owor","year":"2000"},{"key":"10.1002\/14651858.CD003510.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002030-200301030-00009","article-title":"Compliance with antiretroviral regimens to prevent perinatal HIV-1 transmission in Kenya","volume":"17","author":"Kiarie","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB22|cit22","first-page":"Suppl 1:S338-45","article-title":"Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial","volume":"84","author":"Limpongsanurak","year":"2001","journal-title":"Journal of the Medical Association of Thailand"},{"key":"10.1002\/14651858.CD003510.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00006454-199506000-00012","article-title":"Zidovudine for the reduction of perinatal human immunodeficiency virus transmission: Pediatric AIDS Clinical Trials Group Protocol 076 - results and treatment recommendations","volume":"14","author":"Connor","year":"1995","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD003510.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJM199611283352201","article-title":"Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant","volume":"335","author":"Sperling","year":"1996","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/00002030-199814000-00012","article-title":"Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 study","volume":"12","author":"Sperling","year":"1998","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB28|cit27","series-title":"8th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, February 2001","article-title":"Report of results of PACTG 316: An international phase III trial of standard antiretroviral (ARV) prophylaxis plus nevirapine (NVP) for prevention of perinatal HIV transmission","author":"Dorenbaum","year":"2001"},{"key":"10.1002\/14651858.CD003510.pub2-BIB27|cit28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jama.288.2.189","article-title":"Two-dose intrapartum\/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial","volume":"288","author":"Dorenbaum","year":"2002","journal-title":"The Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003510.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(02)08214-4","article-title":"Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB30|cit30","author":"See"},{"key":"10.1002\/14651858.CD003510.pub2-BIB31|cit31","author":"See"},{"key":"10.1002\/14651858.CD003510.pub2-BIB32|cit32","author":"See"},{"key":"10.1002\/14651858.CD003510.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1056\/NEJM200010053431401","article-title":"A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1","volume":"343","author":"Lallemant","year":"2000","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD003510.pub2-BIB34|cit34","author":"See"},{"key":"10.1002\/14651858.CD003510.pub2-BIB35|cit35","author":"See"},{"key":"10.1002\/14651858.CD003510.pub2-BIB36|cit36","first-page":"283","article-title":"Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1","volume":"38","author":"Cressey","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa033500","article-title":"Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand","volume":"351","author":"Lallemant","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB38|cit38","series-title":"XIII International AIDS Conference, Durban","article-title":"Clinical course of HIV infection and surveillance for zidovudine resistance among HIV-infected women receiving short-course zidovudine therapy in Abidjan, Cote d'Ivoire","author":"Sibailly","year":"2000"},{"key":"10.1002\/14651858.CD003510.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(98)10412-9","article-title":"Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'Ivoire: a randomised trial","volume":"353","author":"Wiktor","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1086\/367898","article-title":"A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1","volume":"187","author":"Moodley","year":"2003","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/499967","article-title":"Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1","volume":"193","author":"Eshleman","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB42|cit42","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1179\/027249304225019127","article-title":"Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth","volume":"24","author":"Taha","year":"2004","journal-title":"Annals of Tropical Paediatrics"},{"key":"10.1002\/14651858.CD003510.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(03)14538-2","article-title":"Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial","volume":"362","author":"Taha","year":"2003","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1086\/499967","article-title":"Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1","volume":"193","author":"Eshleman","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1179\/027249304225019127","article-title":"Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth","volume":"24","author":"Taha","year":"2004","journal-title":"Annals of Tropical Paediatrics"},{"key":"10.1002\/14651858.CD003510.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.292.2.202","article-title":"Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial","volume":"292","author":"Taha","year":"2004","journal-title":"The Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD003510.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00002030-200003310-00006","article-title":"Oral zidovudine during labour to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood","volume":"14","author":"Bhadrakom","year":"2000","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1542\/peds.107.1.e5","article-title":"Safety of late in utero exposure to zidovudine in infants born to human immunodeficiency virus-infected mothers: Bangkok","volume":"107","author":"Chotpitaysaunondh","year":"2001","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD003510.pub2-BIB49|cit49","series-title":"XIII International AIDS Conferecce, Durban","article-title":"Predictors of mortality in 18-month postpartum period among HIV-infected women enrolled in a trial of short-course antenatal zidovudine, Bangkok, Thailand","author":"Roongpisuthipong","year":"2000"},{"key":"10.1002\/14651858.CD003510.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(98)10411-7","article-title":"Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial","volume":"353","author":"Shaffer","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD003510.pub2-BIB51|cit51","first-page":"151","article-title":"Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand 1996-1998","volume":"47","author":"Vuthipongse","year":"1998","journal-title":"MMWR"},{"key":"10.1002\/14651858.CD003510.pub2-BIB52|cit52","first-page":"79","article-title":"A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe","volume":"50","author":"Thistle","year":"2004","journal-title":"The Central African Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1590\/S1807-59322005000300005","article-title":"Effect of antiretroviral drugs on maternal CD4 lymphocyte counts, HIV-1 RNA levels, and anthropometric parameters of their neonates","volume":"60","author":"Beitune","year":"2005","journal-title":"Clinics"},{"key":"10.1002\/14651858.CD003510.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00002030-200203080-00016","article-title":"Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa","volume":"16","author":"Leroy","year":"2002","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1097\/01.aids.0000188423.02786.55","article-title":"Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?","volume":"19","author":"Leroy","year":"2005","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00126334-200312150-00006","article-title":"Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months","volume":"34","author":"Shetty","year":"2003","journal-title":"J Acquir Immune Defic Syndr."},{"key":"10.1002\/14651858.CD003510.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S0104-42302005000200017","article-title":"Clinical and laboratory evolution of children born to HIV positive mothers","volume":"51","author":"Yoshimoto","year":"2005","journal-title":"Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"key":"10.1002\/14651858.CD003510.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/jn\/135.4.945","article-title":"Perceptions of the role of maternal nutrition in HIV-positive breast-feeding women in Malawi","volume":"135","author":"Bentley","year":"2005","journal-title":"The Journal of Nutrition"},{"key":"10.1002\/14651858.CD003510.pub2-BIB59|cit59","unstructured":"Ongoing study"},{"key":"10.1002\/14651858.CD003510.pub2-BIB60|cit60","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/aje\/kwg188","article-title":"Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breast-feeding populations: comparing statistical methods","volume":"158","author":"Alioum","year":"2003","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003510.pub2-BIB61|cit61","article-title":"Proportions and their differences","volume-title":"Statistics with confidence","author":"RG","year":"2005"},{"key":"10.1002\/14651858.CD003510.pub2-BIB62|cit62","series-title":"7th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA","article-title":"Review of deaths among a cohort of New York State (NYS) infants exposed in the perinatal period to HIV and antiretroviral drugs [Abstract 692]","author":"Birkhead","year":"2000"},{"key":"10.1002\/14651858.CD003510.pub2-BIB63|cit63","series-title":"Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, USA","article-title":"Zidovudine-lamivudine for prevention of mother to child HIV-1 transmission. Sixth Conference on Retroviruses and Opportunistic Infections [Abstract 267]","author":"Blanche","year":"1999"},{"key":"10.1002\/14651858.CD003510.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1749-6632.2000.tb05491.x","article-title":"Lack of evidence of mitochondrial dysfunction in the offspring of HIV-infected women. Retrospective review of perinatal exposure to antiretroviral drugs in the Perinatal AIDS Collaborative Transmission Study","volume":"918","author":"Bulterys","year":"2000","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1002\/14651858.CD003510.pub2-BIB66|cit66","series-title":"The 12th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA","article-title":"Addition of 3 days of ZDV+3TC postpartum to a short course of ZDV+3TC and single-dose NVP provides low rate of NVP resistance mutations and high efficacy in preventing peri-partum HIV-1 transmission: ANRS DITRAME Plus, Abidijan, Cote d'Ivoire [oral LB72]","author":"Chaix","year":"2005"},{"key":"10.1002\/14651858.CD003510.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment","volume":"331","author":"Connor","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.281.2.151","article-title":"Lack of long-term effects of in utero exposure to zidovudine among uninfected childen born to HIV-infected women","volume":"281","author":"Culnane","year":"1991","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003510.pub2-BIB69|cit69","first-page":"S67","article-title":"Methodology of intervention trials to reduce mother-to-child transmission of HIV with special reference to developing countries","volume":"9 Suppl A","author":"Dabis","year":"1995","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0140-6736(92)92115-V","article-title":"Risk of human immunodeficiency virus type 1 transmission through breast-feeding","volume":"240","author":"Dunn","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB71|cit71","first-page":"1064","article-title":"Mode of delivery and vertical transmission of HIV-1: a review of prospective studies","volume":"7","author":"Dunn","year":"1994","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"15","key":"10.1002\/14651858.CD003510.pub2-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/00002030-200110190-00006","article-title":"Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET012)","volume":"15","author":"Eshleman","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB73|cit73","series-title":"The 12th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA","article-title":"Sensitive drug resistance assays reveal long-term persistence of HIV-1 variants with the K103N nNevirapine-resistance mutation in some women and infants after single-dose NVP: HIV-NET 012 [poster 800]","author":"Eshleman","year":"2005"},{"key":"10.1002\/14651858.CD003510.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/430764","article-title":"Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP","volume":"192","author":"Eshleman","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/0140-6736(92)90534-A","article-title":"Risk factors for mother-to-child transmission of HIV-1. European Collaborative Study","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1002\/sim.1076","article-title":"Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of consensus methodology","volume":"20","author":"Dabis","year":"2001","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB77|cit77","series-title":"The 12th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA","article-title":"Selection of resistance mutations in children receiving prophylaxis with lamivudine or nevirapine for the prevention of postnatal transmission of HIV [oral 99]","author":"Giuliano","year":"2005"},{"key":"10.1002\/14651858.CD003510.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less","volume":"337","author":"Hammer","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/430745","article-title":"Single-dose nevirapine and drug resistance: the more you look, the more you find","volume":"192","author":"Hammer","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB80|cit80","series-title":"7th Conference on Retroviruses and Opportunistic Infections, San Francisco","article-title":"Evaluation of living uninfected children for mitochondrial defects: Women and Infants Transmission Study","author":"Hanson","year":"2000"},{"key":"10.1002\/14651858.CD003510.pub2-BIB81|cit81","series-title":"Conf Retrovirus Opportunistic Infect","article-title":"A meta-analysis of the effects of HIV-1 RNA methodology on estimates of HIV-1 RNA undetectability in trials of HAART","author":"AM","year":"1999"},{"key":"10.1002\/14651858.CD003510.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1","volume":"340","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB83|cit83","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00126334-200312010-00011","article-title":"HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Cote d'Ivoire","volume":"34","author":"Jamieson","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/oxfordjournals.epirev.a017922","article-title":"Mother-to-child transmission of human immunodeficiency virus type 1","volume":"18","author":"John","year":"1996","journal-title":"Epidemiologic Reviews"},{"key":"10.1002\/14651858.CD003510.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/430741","article-title":"Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated","volume":"192","author":"Johnson","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa041305","article-title":"Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy","volume":"351","author":"Jourdain","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1172\/JCI117720","article-title":"Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies","volume":"95","author":"Khouri","year":"1995","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD003510.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199606203342501","article-title":"Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child","volume":"334","author":"Landesman","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"10.1002\/14651858.CD003510.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1001\/jama.285.16.2083","article-title":"Lamivudine-zidovudine combination for prevention of maternal infant transmission of HIV-1","volume":"285","author":"Mandelbrot","year":"2001","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003510.pub2-BIB90|cit90","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(99)80009-9","article-title":"Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa","volume":"354","author":"Marseille","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB91|cit91","series-title":"The 12th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA","article-title":"Controversies in the use of nevirapine for the prevention of mother-to-child transmission [Plenary 7]","author":"McIntyre","year":"2005"},{"key":"10.1002\/14651858.CD003510.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9378(95)90286-4","article-title":"The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficiency virus","volume":"173","author":"Minkoff","year":"1995","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD003510.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/jama.282.8.744","article-title":"HIV transmission through breastfeeding: a study in Malawi","volume":"282","author":"Miotti","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003510.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/515641","article-title":"Pharmacokinetics of nevirapine in human immunodeficiency virus type-1 infected pregnant women and their neonates","volume":"178","author":"Mirochnick","year":"1998","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB95|cit95","first-page":"252","article-title":"Epidemiology and determinants of vertical HIV transmission","volume":"5","author":"Mofenson","year":"1994","journal-title":"Seminars in Pediatric Infectious Diseases"},{"key":"10.1002\/14651858.CD003510.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00006454-199503000-00001","article-title":"A critical review of studies evaluating the relationship of mode of delivery to perinatal transmission of human immunodeficiency virus","volume":"14","author":"Mofenson","year":"1995","journal-title":"Pediatric Infectious Disease Journal"},{"key":"10.1002\/14651858.CD003510.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(00)02504-6","article-title":"AIDS across Europe, 1994-98: the EUROSIDA study","volume":"356","author":"Morcroft","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00042560-200012010-00003","article-title":"Multicentre review of protease inhibitors in 89 pregnancies","volume":"25","author":"Morris","year":"2000","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB99|cit99","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00002030-199903110-00006","article-title":"A phase I\/II study of the safety and pharmacokinetics of nevirapine in HIV-1 infected pregnant Ugandan woman and their neonates (HIVNET 006)","volume":"13","author":"Musoke","year":"1999","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD003510.pub2-BIB100|cit100","first-page":"298","article-title":"Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women","volume":"6","author":"Nair","year":"1993","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1002\/14651858.CD003510.pub2-BIB101|cit101","series-title":"The 12th Conference on Retroviruses and Opportunistic Infections, San Francisco, USA","article-title":"Persistence of NNRTI-r resistant variants after single-dose nevirapine in HIV-1 subtype-C-infected women [poster 101]","author":"Palmer","year":"2005"},{"key":"10.1002\/14651858.CD003510.pub2-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0140-6736(94)93056-2","article-title":"Maternal vitamin A deficiency and mother-to-child transmission of HIV-1","volume":"343","author":"Semba","year":"1994","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB103|cit103","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/bmj.331.7519.742","article-title":"Randomised controlled trials in Africa of HIV and AIDS: descriptive study and spatial distribution","volume":"331","author":"Siegfried","year":"2005","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003510.pub2-BIB104|cit104","unstructured":"UNAIDS\/WHO AIDS epidemic update Geneva: Joint United Nations Programme on HIV\/AIDS (UNAIDS)"},{"key":"10.1002\/14651858.CD003510.pub2-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM199811123392001","article-title":"Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus","volume":"339","author":"Wade","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003510.pub2-BIB106|cit106","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0140-6736(02)09550-8","article-title":"Meeting international goals in child survival and HIV\/AIDS","volume":"360","author":"Walker","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003510.pub2-BIB107|cit107","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00042560-199504120-00011","article-title":"Rates of mother-to-child transmission of HIV-1 in Africa, America and Europe: results of 13 perinatal studies","volume":"8","year":"1995","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology"},{"key":"10.1002\/14651858.CD003510.pub2-BIB108|cit108","first-page":"593","article-title":"Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012","volume":"39","author":"Eshleman","year":"2005","journal-title":"Journal of Acquired Immune Deficiency Syndromes"}],"updated-by":[{"DOI":"10.1002\/14651858.cd003510.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003510.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:21:55Z","timestamp":1628544115000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003510.pub2"}},"subtitle":[],"editor":[{"given":"Jimmy","family":"Volmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":108,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003510.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD003510.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2007,1,24]]}}}